Skip to main content
Frontiers in Public Health logoLink to Frontiers in Public Health
. 2026 May 29;14:1746257. doi: 10.3389/fpubh.2026.1746257

Antibiotic prophylaxis during dental implant surgery treatment in northwest China: a cross-sectional study

Yao Lin 1,†, Jia Ju 1,†, Jing Huang 1,†, Jiao Yue 1,†, Lifei Cheng 1, Yanfei Ma 1, Wen Pan 1, Hongbo Wei 2,*, Bin Feng 1,*
PMCID: PMC13260413  PMID: 42293627

Abstract

Background

This study was designed to investigate the existing status of antibiotic prophylaxis during dental implant surgery in northwest China.

Methods

This cross-sectional study was conducted based on a web survey following the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines. The questionnaire comprised the basic information of respondents, the awareness of antibiotic prophylaxis, and the antimicrobial prescription habits of dentists performing dental implants. The questionnaire was sent individually to 2,099 dentists who performed dental implants in northwest China from April to December 2021. Data were collected and analyzed.

Results

A total of 318 participants responded to the survey. Of the respondents, 65.41% (n = 208) routinely prescribed antibiotics during dental implant surgery, while only 0.94% (n = 3) did not prescribe them. A total of 141 (44.40%) respondents reported concerns regarding the indications for antibiotic use. The most frequently used antibiotics included penicillins, cephalosporins, and nitroimidazoles. Respondents were inclined to prolong antibiotics routinely for more than 24 h, specifically in patients with bone grafts, which reached 85.08%.

Conclusion

Antibiotics are widely used to prevent infection during dental implant surgery in northwest China. Dentists are inclined to prolong the course of antibiotics routinely, both in healthy individuals and patients with bone grafts.

Keywords: antibiotic prescription, bacterial resistance, dental implants, postoperative infection, prescribing patterns

1. Introduction

Antimicrobial resistance (AMR) is a growing threat worldwide with considerable mortality implications. The Global burden of bacterial antimicrobial resistance in 2019 revealed that AMR was associated with an estimated 4.95 million deaths globally, with some authors suggesting that AMR could become the next pandemic if its drivers are not addressed (1, 2). The key driver of AMR is the inappropriate use of antibiotics, especially those from the Watch and Reserve groups with their increased resistance potential (3–6). These concerns led to the instigation of the WHO AWaRe (Access, Watch, Reserve) book to enhance future use of antibiotics—especially important given concerns with the robustness of antibiotic guidelines among low- and middle-income countries. The AWaRe book explicitly states that “Antibiotics are not needed before most dental procedures to prevent surgical site infections” (7, 8), highlighting the urgent need to reassess current antibiotic prophylaxis practices in dentistry.

Dental implant restoration is one of the best treatment options for restoring missing teeth due to positive long-term clinical outcomes (9, 10). However, dental implant failures occur, and bacterial contamination during implant surgery can lead to postoperative infections and early implant failures (11, 12). Dentists worldwide routinely use antibiotics to prevent infections during invasive dental procedures (13). Although several studies show that antibiotic prophylaxis is effective in preventing early implant failures, (11) evidence shows that antibiotic prophylaxis should not be used for “simple” implant procedures in systemically healthy individuals (14, 15). Some studies have examined the prescribing habits of dentists in different countries, including the Netherlands, Spain, Turkey, and Italy, to understand the use of antibiotics in implant surgery (16–19). The results show significant differences in the use of antibiotics in implant surgery.

Currently, there is no international consensus on antibiotic prophylaxis in implant surgery, which has led to large differences in the therapies prescribed by clinicians. Antibiotic prophylaxis during implant surgery is a controversial topic, and there are differing opinions on its necessity, (20, 21) so it is important to identify current prescribing habits during dental implant surgery.

China is among the largest manufacturers and consumers of antibiotics worldwide (22). The resistance rates for multiple pathogens have reached alarming levels (23). A national study, which included 48 healthcare facilities in six provinces in China, found that 52.9% of outpatient visits in primary care settings involved antibiotic use, with only 39.4% of outpatient antibiotic prescriptions deemed appropriate (24). This inappropriate use of antibiotics in primary care settings has contributed to the propagation of resistant organisms, presenting a major public health challenge. Given this context, the routine use of antibiotic prophylaxis for dental implant surgery in healthy patients becomes particularly questionable. Therefore, an action to promote the rational use of antibiotics in China is necessary. However, antibiotic use during dental implant surgery in China remains unclear.

The routine use of antibiotic prophylaxis for dental implant surgery remains controversial. Recent systematic reviews and meta-analyses have demonstrated that routine antibiotic prophylaxis may not be sufficiently effective to justify its use in straightforward implant procedures, and that antibiotics should not be used routinely in dental implant surger (25–28). Despite this, empirical practices and concerns regarding medical disputes contribute to antibiotic overuse in Chinese primary care settings. Dentists remain confused about the benefits of prophylaxis and desire clearer guidelines (13). Thus, research and education are urgently needed to transform prescribing behaviors. Nevertheless, the use of antibiotics during dental implant surgery in China requires more comprehensive investigation. The study aimed to investigate the current situation of antibiotic use and dentists' awareness in northwest China and to provide evidence-based data for developing guidelines for antibiotic prophylaxis during dental implant surgery.

A preprint has previously been published (29).

2. Materials and methods

This study obtained exemption from the ethics committee's review application (No. KQ-YJ-2023-077) because it did not perform any intervention in humans and did not use any personal data or biological samples of human origin. All collected data were completely anonymized. Informed consent was obtained for each questionnaire. This observational cross-sectional study followed the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines (30). All methods were performed following the relevant guidelines and regulations.

2.1. Participants

The Chinese Stomatological Association Oral Implantology Committee is China's largest and most authoritative academic organization for dental implantology. As of April 2021, 6,351 licensed dentists have registered as members, with membership requiring valid medical practitioner certification (http://www.cndent.com/). From April to December 2021, 2,099 dentist members in northwest China accepted to participate in the questionnaire survey circulated via WeChat. During this period, two reminders were sent to those who had not responded to the questionnaire. The hierarchical structure and certification requirements for dental clinical titles in China are detailed in Supplementary Table 1.

2.2. Study design

Based on the circumstances in China, the questionnaire, designed and produced by two experienced dental implantologists and pharmaceutical specialists, aimed to collect data concerning antibiotic prophylaxis prescription habits during dental implant surgery. The research team reviewed the questionnaire for intelligible and logical order. The question regarding the antibiotic regimen was based on published literature. To ensure the accuracy and consistency of all survey questions, a questionnaire prediction was first performed by 10 dentists. The questionnaire comprised three main parts, i.e., the basic information of respondents, the cognition degree, and the current use of antibiotic prophylaxis during dental implant surgery (Table 1).

Table 1.

Questionnaire.

Questionnaire items Response options
Part 1 basic information
1. Your professional title Junior (Resident physician)
Intermediate (Attending physician)
Senior (Deputy Chief Physician/Chief Physician)
2. Your educational background Below Bachelor (Associate degree)
Bachelor (Bachelor of Stomatology)
Master (Master of Stomatological Medicine)
Doctoral (Doctor of Stomatological Medicine)
3. Your majors General stomatology
Oral and maxillofacial surgery
Oral implantology
Prosthodontics
4. Type of your current place of employment Stomatological hospital
Department of Stomatology, general hospital
Dental clinic
5. Number of implants performed per year? ≥100
51–100
≤ 50
Part 2 cognition of antibiotic prophylaxis during dental implant surgery
6. Do you use antibiotics during the perioperative period of a dental implants? Never
Sometimes
Always
7. During the perioperative period of dental implants, which problems do you think need to be provided necessary recommendations? Indications for antibiotic use
Antibiotic types
Course of antibiotic use
Starting time of antibiotic use
Others
8. The reason and necessity of establishing the guideline for antibiotic prophylaxis during dental implant surgery Reducing the overuse of antibiotics
Standardizing the use of antibiotics
Protect professional rights and interests in a lawsuit
Others
Part 3 questions about antibiotic prescription habits during implant surgery
9. When do you use antibiotics during a dental implant surgery? Only preoperative
Pre- and postoperative
Only postoperative
Only in special cases
10. If you suggest preoperative administration, then what is the specific time of administration? More than 1 day prior
1 day prior
1 h prior
Immediately
11. Antibiotic types: assuming that the patients has no antibiotic allergies, which antibiotic do you typically prescribe?(Multiple choice) Penicillins (e.g., amoxicillin)
Cephalosporins (e.g., cefazolin)
Macrolides (e.g., roxithromycin)
Lincomycin (e.g., clindamycin)
Nitroimidazoles (e.g., metronidazole)
Others
12. Course of antibiotics for dental implant surgery in healthy patients? ≤ 24 h
>24 h
13. Course of antibiotics for dental implant surgery in patients with bone grafts? ≤ 24 h
>24 h

2.3. Statistical methods

The SPSS version 22.0 (IBM Corporation, Armonk, NY, USA) software was used for data analysis. Measurement data were expressed as (±s). Students' t-test or analysis of variance (ANOVA) was used for comparison. Count data were assessed using proportions (percentages), and the comparison was conducted using the χ2 test. P < 0.05 indicated a statistically significant difference.

3. Results

3.1. Participants

A total of 318 participants completed and submitted their responses. The response rate was 15.15%.

3.2. Demographic data

All 318 respondents were licensed dentists. Among them, 27.99% held senior professional titles (chief physician or deputy chief physician), 50.94% held intermediate titles (attending physician), and 21.07% held junior titles (resident physician). Regarding education, 48.43% had bachelor's degrees, 27.04% master's degrees, and 11.32% doctoral degrees; 13.21% had education below bachelor's level. No dental technicians or other non-dentist professionals were included in the sample. 49.69% of the respondents performed more than 50 dental implant operations annually (Table 2).

Table 2.

Basic information of the respondents (n = 318).

Basic information of respondents Proportion Habit of prescribing antibiotics (no., %)
(No., %) Never Sometimes Always
Professional qualifications
Junior (Resident physician) 67 (21.07) 1 (1.49) 26 (38.81) 40 (59.70)
Intermediate (Attending physician) 162 (50.94) 2 (1.23) 55 (33.95) 105 (64.82)
Senior (Deputy Chief Physician/Chief Physician) 89 (27.99) 0 (0) 26 (29.21) 63 (70.79)
Total 318 (100.00) 3 (0.94) 107 (33.65) 208 (65.41)
Education background
Below Bachelor (Associate degree) 42 (13.21) 0 (0) 12 (28.57) 30 (71.43)
Bachelor (Bachelor of Stomatology) 154 (48.43) 1 (0.65) 52 (33.77) 101 (65.58)
Master (Master of Stomatological Medicine) 76 (27.04) 2 (2.32) 29 (33.72) 55 (63.95)
Doctoral (Doctor of Stomatological Medicine) 36 (11.32) 0 (0) 14 (38.89) 22 (61.11)
Total 318 (100.00) 3 (0.94) 107 (33.65) 208 (65.41)
Organization
Stomatological hospital 92 (28.93) 3 (3.26) 30 (32.61) 59 (64.13)
Department of Stomatology general hospital 110 (34.59) 0 (0) 38 (34.55) 72 (65.45)
Dental clinic 116 (36.48) 0 (0) 39 (33.62) 77 (66.38)
Total 318 (100.00) 3 (0.94) 107 (33.65) 208 (65.41)
Professional types
General stomatology 196 (61.64) 1 (0.51) 67 (34.18) 128 (65.31)
Oral and maxillofacial surgery 38 (11.95) 1 (2.63) 13 (34.21) 24 (63.16)
Oral implantology 51 (16.04) 0 (0) 10 (19.61) 41 (80.39)
Prosthodontics 33 (10.38) 1 (3.03) 17 (51.52) 15 (45.45)
Total 318 (100.00) 3 (0.94) 107 (33.65) 208 (65.41)
Number of implants placed per year
≥100 88 (27.67) 0 (0) 26 (29.55) 62 (70.45)
51–100 70 (22.01) 1 (1.43) 19 (27.14) 50 (71.43)
≤ 50 16,050.31 2 (1.25) 62 (38.75) 96 (60.00)
Total 318 (100.00) 3 (0.94) 107 (33.65) 208 (65.41)

3.3. Current status of antibiotic prophylaxis in dental implant surgery

The results of our survey showed that 65.41% of dentists (n = 208) routinely prescribed antibiotics, 0.94% (n = 3) stated that they never prescribed any antibiotics and 33.65% (n = 107) respondents prescribed antibiotics when the patients had an underlying disease (Table 2).

3.4. Cognition of antibiotic prophylaxis

The questionnaire included questions to survey the dentists' desire to learn about antibiotic use in implant surgery. A total of 43.81% of respondents wanted to know the indication of antibiotic use, 27.93% desired to know recommendations of antibiotic types, 15.56% about the duration of antibiotic use, and 11.43% about the initiation duration of antibiotic prophylaxis (Figure 1).

Figure 1.

Pie chart illustrating reasons for antibiotic prescribing information, with 43.81 percent for indications, 27.93 percent for types, 15.56 percent for duration, 11.43 percent for starting time, and 1.27 percent for others.

Questions about antibiotic use in dental implant surgery that the dentists desired to learn. This figure shows the questions dentists wanted to explore regarding antibiotic use in implant surgery, including indications, types, and duration of antibiotics.

To establish guidelines for dental implant antibiotic prophylaxis, 77.36% of respondents considered that these could restrain doctors from prescribing more stringently, thus reducing the overuse of antibiotics and standardizing prescriptions among clinicians. 48.11% of respondents considered that these could protect practitioners in litigation cases, and 7.86% considered that these could reduce antimicrobial resistance.

3.5. Current status of antibiotic prophylaxis in dental implant surgery

3.5.1. Timing of antibiotic prophylaxis

Except for three respondents who reported never prescribing antibiotics, 315 respondents prescribed antibiotics during implant surgery. Among them, 74.60% of respondents prescribed antibiotics pre-and post-operatively, 4.13% prescribed them only pre-operatively, and 15.87% prescribed antibiotics post-operatively (Table 3). 248 respondents who prescribed antibiotics pre-operatively during implant surgery advised their patients to start the regimen 1 h before surgery, accounting for 54.03 and 23.79% 1 day before the surgery (Table 4).

Table 3.

Regimens and starting time of the medication (n = 315).

n/% n % n %
Category
Only pre-operative 4.13%
More than 1 day prior 1 7.69% 13
1 day prior 1 7.69%
1 h prior 9 69.23%
Immediately 2 15.38%
Pre- and postoperative 74.60%
More than 1 day prior 39 16.60% 235
1 day prior 58 24.68%
1 h prior 125 53.19%
Immediately 13 5.53%
Only postoperative 50 15.87%
Only in special cases 17 5.40%
Total 315 100.00
Table 4.

Antibiotics pre-operative during implant surgery.

n/% n %
Category
More than 1 day prior 40 16.13%
1 day prior 59 23.79%
1 h prior 134 54.03%
Immediately 15 6.05%
Total 248 100%

3.5.2 Type of antibiotics prescribed

The results of the questionnaire survey showed that nitroimidazoles, penicillins, and cephalosporins were the most commonly prescribed types of antibiotic prophylaxis in dental implant surgery (Figure 2). Considering the predominance of anaerobes in oral infections, respondents preferred the combination of nitroimidazoles. A total of 37.14% of respondents prescribed nitroimidazoles in combination with penicillin, and 31.11% prescribed nitroimidazoles in combination with cephalosporins (Figure 3). Nitroimidazoles accounted for the highest proportion (Figure 2).

Figure 2.

Horizontal bar chart comparing percentage of respondents using two antibiotic combinations: Cephalosporins with Nitromidazoles at thirty-one point one one percent and Penicillins with Nitromidazoles at thirty-seven point one four percent.

Proportion of antibiotic types. This figure displays the distribution of antibiotic types dentists prescribe during dental implant surgery.

Figure 3.

Horizontal bar chart showing the percentage of respondents using different antibiotic classes: Nitroimidazoles sixty-two point five four percent, Penicillins fifty-nine point six eight percent, Cephalosporins fifty-three point three three percent, Macrolides ten point seven nine percent, Lincomycin seven point six two percent, Others one point nine percent.

Combination of antibiotic types. This figure illustrates the various combinations of antibiotics, such as nitroimidazoles with penicillin or cephalosporins, used in dental implant surgeries.

3.5.3. Regimens of antibiotic prophylaxis

According to the guideline specified in the Clinical Application of Antibiotics in China (2015), most maxillofacial surgeries are clean-contaminated surgeries, and the duration of antibiotic prophylaxis is less than 24 h. For healthy patients, 44.13% of respondents prescribed antibiotics for less than 24 h and 55.87% for more than 24 h. Among 55.87% of the respondents, those with primary, middle, and senior degrees accounted for 50, 53.13, and 65.17%, respectively. The respondents from the stomatological hospital, department of stomatology general hospital, and dental clinics accounted for 48.31, 56.26, and 61.21%, respectively (Table 5).

Table 5.

Regimens of antibiotics prescribed for healthy patients during dental implant surgery (n = 315).

n/% ≤ 24 h/% >24 h/%
Category n % n %
Professional qualifications
Junior (Resident physician) 33 50.00 33 50.00
Intermediate (Attending physician) 75 46.87 85 53.13
Senior (Deputy Chief Physician/Chief Physician) 31 34.83 58 65.17
Organization
Stomatological hospital 46 51.69 43 48.31
Department of Stomatology general hospital 48 43.64 62 56.26
Dental clinic 45 38.79 71 61.21
Total 139 44.13 176 55.87

During dental implant surgery with bone grafts, 85.08% of respondents prescribed antibiotics for more than 24 h, and those with primary, middle, and senior degrees accounted for 81.82, 83.75, and 89.89%, respectively. Among the 85.08% of respondents, those from the stomatological hospital, department of stomatology general hospital, and dental clinics accounted for 83.15, 83.64, and 87.93%, respectively. The duration of antibiotics for patients with bone grafts was longer than that for healthy individuals (Table 6).

Table 6.

Regimens of antibiotics prescription during dental implant surgery for patients with bone grafts (n = 315).

n/% ≤ 24 h/% >24 h/%
Category n % n %
Professional qualifications
Junior (Resident physician) 12 18.18 54 81.82
Intermediate (Attending physician) 26 16.25 134 83.75
Senior (Deputy Chief Physician/Chief Physician) 9 10.11 80 89.89
Organization
Stomatological hospital 15 16.85 74 83.15
Department of Stomatology general hospital 18 16.36 92 83.64
Dental clinic 14 12.07 102 87.93
Total 47 14.92 268 85.08

4 Discussion

This is a wide-ranging study concerning antibiotic prescriptions for dental implant surgery in China. All survey respondents were from northwest China, including stomatological hospitals, the Department of Stomatology in General Hospital, and dental clinics. Antibiotics are widely used during dental implant surgery in northwest China. Respondents prescribe their patients different drugs for different durations, with varying starting durations of antibiotic prophylaxis for the same implant surgery not only in China but also in other countries, including the Netherlands, (8) the UK, (5) Italy (11), and the U.S.A. (31). In China, the preferred antibiotic types in dental implant surgery were penicillins, cephalosporins, and nitroimidazoles. The duration of antibiotics during dental implant placement for patients with bone grafts usually exceeds 24 h. Among the respondents, 74.6% prescribed antibiotics both pre- and post-operative. Few respondents were aware of the evidence published to date, such as prescribing a single oral dose 1 h pre-operative (21, 32). Public awareness of antibiotic resistance needs to be improved (33). Without antibiotics, a surge in disputed cases of dental implants in China is likely to occur. Therefore, 48.11% of respondents believed that the development of guidelines could protect practitioners in litigation of medical disputes.

This finding is particularly concerning given the recent WHO AWaRe recommendations explicitly stating that antibiotics are not required before most dental procedures to prevent surgical site infections (7, 8). The considerable variation observed in our study, with 65.41% of dentists routinely prescribing antibiotics, suggests a significant gap between current practice in northwest China and global stewardship goals. The prescribing habits of antibiotics during implant surgery varied greatly across different countries. In Italy, (19) 84% of dentists in the Netherlands routinely prescribe antibiotics to prevent infection, but only 43.7% prescribe them (16). According to our survey, only 0.94% of people in China have never used antibiotics to prevent infection. In comparison, 3.3% in the Netherlands, (16) 13% in the UK, (13) and 25.9% in Santo Domingo, Dominican Republic (34) dentists performed implant surgery without using antibiotics. Although most dentists prescribe antibiotic prophylaxis, its protocols remain controversial for implant surgery (35). Several studies and reviews have indicated that antibiotic use had no efficacy in healthy individuals; on the contrary, it results in more adverse reactions and may lead to antibiotic resistance (36–38). Evidence has shown dental implants have a high success rate (39). The skill of dentists, the sterile environment of the surgical site, rigorous procedure, and the use of chlorhexidine pre- and post-operative are the important factors for the success of dental implant surgery (35). Recently, a consensus on preventive antibiotic therapy in dental implant procedures in Spain has recommended that no antibiotic prescription for patients be considered wrong (21). A growing body of evidence has shown the need for antibiotics use in special populations, such as patients with diabetes and those requiring bone grafts. Therefore, a more detailed questionnaire survey and professional analysis are needed in China to determine the use of antibiotics in oral implantology, which needs to be based on the patient's comorbidities and the difficulty of the surgery.

Our results showed that the common types of prophylactic antibiotics in dental implant surgery in China are penicillins, cephalosporins, and nitroimidazoles. Amoxicillin, amoxicillin-clavulanate, and metronidazole are the main types used in other countries (16, 19, 40, 41). According to the guidelines specified in China's Clinical Application of Antibiotics (2015), streptococcus and anaerobic bacteria are the main bacteria causing oral infections. The preferred treatment is using amoxicillin or amoxicillin clavulanic acid. For antibiotic types, the results reported were different from the recommendations in guidelines and evidence from the literature. This may be because approximately 10%−20% of patients stated an allergic reaction to penicillin. Many people have been considered “penicillin allergic” since their childhood in China. Therefore, dentists in China choose cephalosporins with a low incidence of allergic reactions. However, significant IgE-mediated or Tlymphocyte-mediated penicillin hypersensitivity is uncommon in clinical settings (42–44). Moreover, studies have shown that 80%−99% of these patients may no longer be considered allergic after allergy testing (45, 46). Most doctors do not question the possibility of incorrect labeling in China. Therefore, this questionnaire did not address the proportion of other antibiotic options for individuals with penicillin allergies, which is inaccurate. Accurate labeling of penicillin allergy in China is necessitated.

According to the guidelines in the Clinical Application of Antibiotics (2015) in China, oral surgery through oropharyngeal mucosa is a clean-contamination surgery. The antibiotic prophylaxis duration is usually less than 24 h. This survey showed that only 44.13% of respondents prescribed antibiotics for less than 24 h in healthy individuals, and 85.08% prescribed antibiotics for more than 24 h in patients with bone grafts. The respondents who prescribed antibiotics for more than 24 h had the highest qualifications. There was a significant correlation between the medical practitioner's qualification and the complexity of implant treatment, similar to the results of a Spanish study (47). The survey showed that over 80% of participants wanted standards established for antibiotic use in dental implant surgery. There are no references for the relationship between the difficulty of dental implant surgery and infection. It is unclear whether there is a need to distinguish between the use of antibiotics according to operation difficulty.

Our findings reveal a critical evidence-practice gap: 65.41% of dentists routinely prescribed antibiotics despite the WHO AWaRe book explicitly stating that antibiotics are not needed before most dental procedures (7, 8). Currently, China lacks specific national guidelines for antibiotic prophylaxis in dental implant surgery, forcing clinicians to rely on general antimicrobial guidelines that inadequately address procedure-specific nuances. National consensus guidelines are urgently needed to: (1) restrict routine antibiotic prophylaxis to high-risk cases (complex surgeries, immunocompromised patients); (2) standardize prescribing across clinical settings; (3) establish single-dose preoperative protocols when antibiotics are indicated; and (4) provide medico-legal clarity to address litigation concerns driving overuse. Recent evidence indicates that routine prophylaxis may not provide clinical benefit but increases adverse events, routine prophylaxis in healthy patients offers minimal clinical benefit (NNT >5) while contributing to adverse events and antimicrobial resistance (25, 48). With 80% of surveyed dentists desiring standardized protocols, the timing for guideline development is particularly opportune. We recommend that the Chinese Stomatological Association and National Health Commission convene expert panels to develop evidence-based guidelines aligned with international best practices, accompanied by targeted educational initiatives to transform prescribing behaviors. In conclusion, dual strategies are required: continued education to reduce overuse at the primary care level, and urgent establishment of national-level, procedure-specific guidelines to standardize practice.

This study has some limitations that warrant consideration. First, the questionnaire was limited, so it could not assess patients' physiological conditions. Second, cross-sectional studies cannot draw causal judgments. Prospective and systematic clinical studies are needed to determine the initiation time and antibiotic prophylaxis regimens in dental implant surgery. Fortunately, northwest China has a large population, and the questionnaire data are representative.

5. Conclusion

In summary, dentists widely use antibiotics to prevent infection during dental implant surgery in northwest China. However, there were several differences in the types, regimens, and antibiotic prophylaxis regimens. Therefore, it is urgent to issue relevant guidelines and establish a consensus to standardize antibiotic use in dental implant surgery to reduce overuse and prevent antibiotic resistance.

Author's note

This article has been published in a preprint version. The link to the preprint is as follows: https://www.researchsquare.com/article/rs-3871632/latest.

Acknowledgments

The authors are very grateful to the Chinese Stomatological Association Oral Implantology Committee specialist member network, which provides the contact information for sending questionnaires. We thank all those who participated in this study.

Funding Statement

The author(s) declared that financial support was received for this work and/or its publication. This work was supported by the Hospital New technology and new Business Funding Project [grant number LX2020-421] and the National Clinical Research Center for Oral Diseases [grant number LCB202218].

Edited by: Ivana Šutej, University of Zagreb, Croatia

Reviewed by: Brian Godman, Sefako Makgatho Health Sciences University, South Africa

Arianit Jakupi, University for Business and Technology (UBT), Albania

Abbreviations: STROBE, Strengthening the Reporting of Observational Studies in Epidemiology; ANOVA, analysis of variance.

Data availability statement

The original contributions presented in the study are included in the article/Supplementary material, further inquiries can be directed to the corresponding author.

Ethics statement

This study was obtained exemption from review application by Ethics Committee (No. KQ-YJ-2023-077), because this study did not perform any intervention in humans and it did not use any personal data or biological samples of human origin. All collected data were completely anonymized. Informed consent was obtained for each questionnaire. The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study.

Author contributions

YL: Conceptualization, Writing – review & editing, Data curation, Methodology, Writing – original draft. JJ: Data curation, Validation, Writing – review & editing, Methodology, Writing – original draft. JH: Writing – review & editing, Writing – original draft, Methodology. JY: Writing – review & editing, Writing – original draft. LC: Writing – review & editing, Data curation, Validation, Writing – original draft. YM: Writing – review & editing, Data curation, Writing – original draft, Conceptualization. WP: Writing – original draft, Data curation, Validation, Writing – review & editing. HW: Writing – original draft, Conceptualization, Data curation, Writing – review & editing. BF: Project administration, Data curation, Writing – original draft, Methodology, Conceptualization, Writing – review & editing.

Conflict of interest

The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Generative AI statement

The author(s) declared that generative AI was not used in the creation of this manuscript.

Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Supplementary material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fpubh.2026.1746257/full#supplementary-material

Table_1.docx (17KB, docx)

References

  • 1.Gautam A. Antimicrobial resistance: the next probable pandemic. JNMA J Nepal Med Assoc. (2022) 60:225–8. doi: 10.31729/jnma.7174 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Patra M, Gupta AK, Kumar D, Kumar B. Antimicrobial resistance: a rising global threat to public health. Infect Drug Resist. (2025) 18:5419–37. doi: 10.2147/IDR.S530557 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Sulis G, Sayood S, Katukoori S, Bollam N, George I, Yaeger LH, et al. Exposure to World Health Organization's AWaRe antibiotics and isolation of multidrug resistant bacteria: a systematic review and meta-analysis. Clin Microbiol Infect. (2022) 28:1193–202. doi: 10.1016/j.cmi.2022.03.014 [DOI] [PubMed] [Google Scholar]
  • 4.Abejew AA, Wubetu GY, Fenta TG. Relationship between antibiotic consumption and resistance: a systematic review. Can J Infect Dis Med Microbiol. (2024) 2024:9958678. doi: 10.1155/2024/9958678 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Wang L, Chen H, Zhang Y, Tian Y, Hu X, Wu J, et al. Global antibiotic consumption and regional antimicrobial resistance, 2010-21: an analysis of pharmaceutical sales and antimicrobial resistance surveillance data. Lancet Glob Health. (2025) 13:e1880–91. doi: 10.1016/S2214-109X(25)00308-0 [DOI] [PubMed] [Google Scholar]
  • 6.Klein EY, Milkowska-Shibata M, Tseng KK, Sharland M, Gandra S, Pulcini C, et al. Assessment of WHO antibiotic consumption and access targets in 76 countries, 2000-15: an analysis of pharmaceutical sales data. Lancet Infect Dis. (2021) 21:107–15. doi: 10.1016/S1473-3099(20)30332-7 [DOI] [PubMed] [Google Scholar]
  • 7.Zanichelli V, Sharland M, Cappello B, Moja L, Getahun H, Pessoa-Silva C, et al. The WHO AWaRe (Access, Watch, Reserve) antibiotic book and prevention of antimicrobial resistance. Bull World Health Organ. (2023) 101:290–6. doi: 10.2471/BLT.22.288614 [DOI] [Google Scholar]
  • 8.Jamil E, Saleem Z, Godman B, Ullah M, Amir A, Haseeb A, et al. Global variation in antibiotic prescribing guidelines and the implications for decreasing AMR in the future. Front Pharmacol. (2025) 16:1600787. doi: 10.3389/fphar.2025.1600787 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Oh SL, Shiau HJ, Reynolds MA. Survival of dental implants at sites after implant failure: a systematic review. J Prosthet Dent. (2020) 123:54–60. doi: 10.1016/j.prosdent.2018.11.007 [DOI] [PubMed] [Google Scholar]
  • 10.Chrcanovic BR, Kisch J, Albrektsson T, Wennerberg A. Factors influencing early dental implant failures. J Dent Res. (2016) 95:995–1002. doi: 10.1177/0022034516646098 [DOI] [PubMed] [Google Scholar]
  • 11.Esposito M, Grusovin MG, Worthington HV. Interventions for replacing missing teeth: antibiotics at dental implant placement to prevent complications. Cochrane Database Syst Rev. (2013) 2013:CD004152. doi: 10.1002/14651858.CD003878.pub5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Pye AD, Lockhart DE, Dawson MP, Murray CA, Smith AJ. A review of dental implants and infection. J Hosp Infect. (2009) 72:104–10. doi: 10.1016/j.jhin.2009.02.010 [DOI] [PubMed] [Google Scholar]
  • 13.Williams RGM. Antibiotic prophylaxis during dental implant placement in the UK. Br Dent J. (2020) 229:787–92. doi: 10.1038/s41415-020-2352-6 [DOI] [PubMed] [Google Scholar]
  • 14.Klinge B, Flemming T, Cosyn J, De Bruyn H, Eisner BM, Hultin M, et al. The patient undergoing implant therapy. Summary and consensus statements. The 4th EAO Consensus Conference 2015. Clin Oral Implants Res. (2015) 26 Suppl 11:64–7. doi: 10.1111/clr.12675 [DOI] [PubMed] [Google Scholar]
  • 15.Lund B, Hultin M, Tranaeus S, Naimi-Akbar A, Klinge B. Complex systematic review - perioperative antibiotics in conjunction with dental implant placement. Clin Oral Implants Res. (2015) 26 Suppl 11:1–14. doi: 10.1111/clr.12637 [DOI] [PubMed] [Google Scholar]
  • 16.Rodriguez Sanchez F, Arteagoitia I, Rodriguez Andres C, Bruers J. Antibiotic prophylaxis prescribing habits in oral implant surgery in the Netherlands: a cross-sectional survey. BMC Oral Health. (2019) 19:281. doi: 10.1186/s12903-019-0981-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Arteagoitia I, Rodriguez-Andres C, Rodriguez-Sanchez F. Antibiotic prophylaxis habits in dental implant surgery among dentists in Spain. A cross-sectional survey. Med Oral Patol Oral Cir Bucal. (2018) 23:e608–18. doi: 10.4317/medoral.22626 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Yalcin-Ulker GM, Cakir M, Meral DG. Antibiotic prescribing habits of the clinicians dealing with dental implant surgery in Turkey: a questionnaire study. Int J Implant Dent. (2020) 6:66. doi: 10.1186/s40729-020-00252-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Rodriguez Sanchez F, Arteagoitia I, Rodriguez Andres C, Caiazzo A. Antibiotic prophylaxis habits in oral implant surgery among dentists in Italy: a cross-sectional survey. BMC Oral Health. (2019) 19:265. doi: 10.1186/s12903-019-0943-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Fluent MT, Jacobsen PL, Hicks LA. Considerations for responsible antibiotic use in dentistry. J Am Dent Assoc. (2016) 147:683–6. doi: 10.1016/j.adaj.2016.04.017 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Salgado-Peralvo AO, Garcia-Sanchez A, Kewalramani N, Barone A, Martinez-Gonzalez JM, Velasco-Ortega E, et al. Consensus report on preventive antibiotic therapy in dental implant procedures: summary of recommendations from the Spanish society of implants. Antibiotics. (2022) 11:655. doi: 10.3390/antibiotics11050655 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Zhang QQ, Ying GG, Pan CG, Liu YS, Zhao JL. Comprehensive evaluation of antibiotics emission and fate in the river basins of china: source analysis, multimedia modeling, and linkage to bacterial resistance. Environ Sci Technol. (2015) 49:6772–82. doi: 10.1021/acs.est.5b00729 [DOI] [PubMed] [Google Scholar]
  • 23.Hu FP, Guo Y, Zhu DM, Wang F, Jiang XF, Xu YC, et al. Resistance trends among clinical isolates in China reported from CHINET surveillance of bacterial resistance, 2005-2014. Clin Microbiol Infect. (2016) 22 Suppl 1:S9–14. doi: 10.1016/j.cmi.2016.01.001 [DOI] [PubMed] [Google Scholar]
  • 24.Wang J, Wang P, Wang XH, Zheng YD, Xiao YH. Use and prescription of antibiotics in primary health care settings in China. JAMA Intern Med. (2014) 174:1914–20. doi: 10.1001/jamainternmed.2014.5214 [DOI] [PubMed] [Google Scholar]
  • 25.Torof E, Morrissey H, Ball PA. Antibiotic use in dental implant procedures: a systematic review and meta-analysis. Medicina. (2023) 59:713. doi: 10.3390/medicina59040713 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Karameh R, Abu-Ta'a M. A systematic review of antibiotic use in dental implant therapy: efficacy, guidelines, and recommendations. Open Dent J. (2023) 17:E18742106266572. doi: 10.2174/0118742106266572231011043237 [DOI] [Google Scholar]
  • 27.Scott Froum D. Antibiotics: Are They Needed for Dental Implant Placement? (2022). Available online at: https://www.perioimplantadvisory.com/clinical-tips/article/14286457/antibiotics-are-they-needed-for-dental-implant-placement (Accessed March 1, 2024).
  • 28.Resnik RR, Misch C. Prophylactic antibiotic regimens in oral implantology: rationale and protocol. Implant Dent. (2008) 17:142–50. doi: 10.1097/ID.0b013e3181752b09 [DOI] [PubMed] [Google Scholar]
  • 29.Lin Y, Huang J, Yue J, Cheng L, Ma Y, Pan W, et al. Antibiotic prophylaxis during dental implant surgery treatment in northwest China: a cross-sectional study. Res. Sq. [Preprint]. doi: 10.21203/rs.3.rs-3871632/v1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Int J Surg. (2014) 12:1495–9. doi: 10.1016/j.ijsu.2014.07.013 [DOI] [PubMed] [Google Scholar]
  • 31.Holz M, Naavaal S, Stilianoudakis S, Carrico C, Byrne BE, Myers GL. Antibiotics and antimicrobial resistance: evaluation of the knowledge, attitude, and perception among students and faculty within US dental schools. J Dent Educ. (2021) 85:383–91. doi: 10.1002/jdd.12445 [DOI] [PubMed] [Google Scholar]
  • 32.Romandini M, De Tullio I, Congedi F, Kalemaj Z, D'Ambrosio M, Lafori A, et al. Antibiotic prophylaxis at dental implant placement: which is the best protocol? A systematic review and network meta-analysis. J Clin Periodontol. (2019) 46:382–95. doi: 10.1111/jcpe.13080 [DOI] [PubMed] [Google Scholar]
  • 33.Sukumar S, Martin FE, Hughes TE, Adler CJ. Think before you prescribe: how dentistry contributes to antibiotic resistance. Aust Dent J. (2020) 65:21–9. doi: 10.1111/adj.12727 [DOI] [PubMed] [Google Scholar]
  • 34.Aragoneses JM, Aragoneses J, Brugal VA, Algar J, Suarez A. Antimicrobial prescription habits of dentists performing dental implant treatments in Santo Domingo, Dominican Republic. Antibiotics. (2020) 9:376. doi: 10.3390/antibiotics9070376 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Momand P, Becktor JP, Naimi-Akbar A, Tobin G, Gotrick B. Effect of antibiotic prophylaxis in dental implant surgery: a multicenter placebo-controlled double-blinded randomized clinical trial. Clin Implant Dent Relat Res. (2022) 24:116–24. doi: 10.1111/cid.13068 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Park J, Tennant M, Walsh LJ, Kruger E. Is there a consensus on antibiotic usage for dental implant placement in healthy patients? Aust Dent J. (2018) 63:25–33. doi: 10.1111/adj.12535 [DOI] [PubMed] [Google Scholar]
  • 37.Salgado-Peralvo AO, Mateos-Moreno MV, Velasco-Ortega E, Pena-Cardelles JF, Kewalramani N. Preventive antibiotic therapy in bone augmentation procedures in oral implantology: a systematic review. J Stomatol Oral Maxillofac Surg. (2022) 123:74–80. doi: 10.1016/j.jormas.2021.01.011 [DOI] [PubMed] [Google Scholar]
  • 38.Rutkowski JL. What is the proper antibiotic prophylaxis regimen for dental implant placement? J Oral Implantol. (2021) 47:269–70. doi: 10.1563/aaid-joi-D-21-Editorial.4704 [DOI] [PubMed] [Google Scholar]
  • 39.Alghamdi HS, Jansen JA. The development and future of dental implants. Dent Mater J. (2020) 39:167–72. doi: 10.4012/dmj.2019-140 [DOI] [PubMed] [Google Scholar]
  • 40.Datta R, Grewal Y, Batth JS, Singh A. Current trend of antimicrobial prescription for oral implant surgery among dentists in India. J Maxillofac Oral Surg. (2014) 13:503–7. doi: 10.1007/s12663-013-0567-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Deeb GR, Soung GY, Best AM, Laskin DM. Antibiotic prescribing habits of oral and maxillofacial surgeons in conjunction with routine dental implant placement. J Oral Maxillofac Surg. (2015) 73:1926–31. doi: 10.1016/j.joms.2015.05.024 [DOI] [PubMed] [Google Scholar]
  • 42.Shenoy ES, Macy E, Rowe T, Blumenthal KG. Evaluation and management of penicillin allergy: a review. JAMA. (2019) 321:188–99. doi: 10.1001/jama.2018.19283 [DOI] [PubMed] [Google Scholar]
  • 43.MacFadden DR, LaDelfa A, Leen J, Gold WL, Daneman N, Weber E, et al. Impact of reported beta-lactam allergy on inpatient outcomes: a multicenter prospective cohort study. Clin Infect Dis. (2016) 63:904–10. doi: 10.1093/cid/ciw462 [DOI] [PubMed] [Google Scholar]
  • 44.Inglis JM, Caughey GE, Smith W, Shakib S. Documentation of penicillin adverse drug reactions in electronic health records: inconsistent use of allergy and intolerance labels. Intern Med J. (2017) 47:1292–7. doi: 10.1111/imj.13558 [DOI] [PubMed] [Google Scholar]
  • 45.Trubiano JA, Adkinson NF, Phillips EJ. Penicillin allergy is not necessarily forever. JAMA. (2017) 318:82–3. doi: 10.1001/jama.2017.6510 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Salgado-Peralvo AO, Uribarri A, Pena-Cardelles JF, Kewalramani N, Rodriguez JLG, Velasco-Ortega E. Does the prosthetic phase of dental implants justify the prescription of preventive antibiotics in healthy patients? A Systematic Review. J Oral Implantol. (2023) 49:93–101. doi: 10.1563/1548-1336-49.1.93 [DOI] [PubMed] [Google Scholar]
  • 47.Camacho-Alonso F, Munoz-Camara D, Sanchez-Siles M. Attitudes of dental implantologists in Spain to prescribing antibiotics, analgesics and anti-inflammatories in healthy patients. Med Oral Patol Oral Cir Bucal. (2019) 24:e752–8. doi: 10.4317/medoral.23103 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Lou A, Zhu X, Pei H, Zhou J, Li M. Effect of preoperative antibiotic use on the implant success rate: a retrospective cohort study of cefixime and ornidazole in China. BMC Oral Health. (2025) 25:1466. doi: 10.1186/s12903-025-06853-y [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Table_1.docx (17KB, docx)

Data Availability Statement

The original contributions presented in the study are included in the article/Supplementary material, further inquiries can be directed to the corresponding author.


Articles from Frontiers in Public Health are provided here courtesy of Frontiers Media SA

RESOURCES